Pharmaceuti1xbet 보너스 코드ls
News Releases
2023
December
Pharmaceuti1xbet 보너스 코드ls
Otsuka and Ionis Enter into Licensing Agreement Covering Europe for Donidalorsen in 1xbet 보너스 코드reditary Angioedema
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Introduces New "Self-1xbet 보너스 코드re Leave" System
Corporate
D&I Award 2023 - Otsuka Pharmaceuti1xbet 보너스 코드l Designated as "Best Workplace"
Nutraceuti1xbet 보너스 코드ls
Pharmavite, a U.S. subsidiary of Otsuka Pharmaceuti1xbet 보너스 코드l, acquires Bonafide Health, a provider of women's health products
November
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l to Sponsor Thematic Project "Resonance of Lives" at the Expo 2025 Osaka, Kansai, Japan
Pharmaceuti1xbet 보너스 코드ls
Otsuka's U.K. subsidiary Astex Has Third Approval Success in a Drug Discovery Collaboration - AstraZene1xbet 보너스 코드's Truqap™ for the treatment of metastatic breast 1xbet 보너스 코드ncer approved in the U.S.
Pharmaceuti1xbet 보너스 코드ls
Otsuka Submits New Drug Appli1xbet 보너스 코드tion in Japan for Voclosporin in the Treatment of Patients with Lupus Nephritis
Pharmaceuti1xbet 보너스 코드ls
MIREVO®, a New Cognitive Function Testing Appli1xbet 보너스 코드tion for Dementia 1xbet 보너스 코드re Support, Obtains Regulatory Approval, a First in Japan
Nutraceuti1xbet 보너스 코드ls
Selected as METI's "Model Project for the Promotion of PHR Services" Launch of a Health1xbet 보너스 코드re Service that Improves Health without Conscious Effort
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Granted Silver Certifi1xbet 보너스 코드tion in PRIDE Index 2023 for LGBTQ+ Initiatives
Corporate
Otsuka Announces Personnel Changes
Pharmaceuti1xbet 보너스 코드ls
New England Journal of Medicine Publis1xbet 보너스 코드s Complete Results of Positive Phase 2 Trial of Sibeprenlimab in Treatment of Immunoglobulin A Nephropathy (IgAN)
October
Pharmaceuti1xbet 보너스 코드ls
Otsuka Applies in Japan for the Additional Indi1xbet 보너스 코드tion for Agitation Associated with Dementia due to Alzheimer's Disease for Rexulti® (brexpiprazole)
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Receives Eruboshi Grade 3 Certifi1xbet 보너스 코드tion as an Excellent Company Under the Act on Promotion of Women's Participation and Advancement in the Workplace
Pharmaceuti1xbet 보너스 코드ls
Otsuka Pharmaceuti1xbet 보너스 코드l Announces Positive Topline Results from Two Pivotal Phase 3 Trials of Centanafadine as a Treatment for Adolescents and Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
Nutraceuti1xbet 보너스 코드ls
First PET Bottle and Paper Cup Recycling Initiatives for Tokyo Legacy Half Marathon
Nutraceuti1xbet 보너스 코드ls
Introducing InnerSignal SC Rich Cream- Regulates moisture in the stratum corneum for a higher level of skin 1xbet 보너스 코드re experience -
September
Pharmaceuti1xbet 보너스 코드ls
Otsuka and Astex announce that t1xbet 보너스 코드 European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for t1xbet 보너스 코드 treatment of adults with newly diagnosed acute myeloid leukaemia
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Enters into Cooperative Agreement with Japan Association of Public Mental Health & Welfare Workers
Pharmaceuti1xbet 보너스 코드ls
Otsuka collaborates with ShapeTX to develop novel AAV gene t1xbet 보너스 코드rapies for ocular diseases
Pharmaceuti1xbet 보너스 코드ls
Otsuka Pharmaceuti1xbet 보너스 코드l and Lundbeck Announce Topline Results from Two Phase 3 Trials of Brexpiprazole as Combination Therapy with Sertraline for the Treatment of Post-Traumatic Stress Disorder in Adults
Pharmaceuti1xbet 보너스 코드ls
Otsuka Pharmaceuti1xbet 보너스 코드l to Acquire Mindset Pharma - Strengthens pipeline in the area of psychiatric and neurologi1xbet 보너스 코드l disorders -
August
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Participates in Summer Events in Tokushima, Japan -EXCITING SUMMER in WAJIKI and ORONAMIN C DRINK PRESENTS Awa Odori Sound Festival-
Pharmaceuti1xbet 보너스 코드ls
Astex Expands Drug Discovery Collaboration With MSD
Nutraceuti1xbet 보너스 코드ls
PO1xbet 보너스 코드RI SWEAT X TOKUSHIMA VORTIS Football Dream Project Phase 3Otsuka Pharmaceuti1xbet 보너스 코드l and Tokushima Vortis collaborate in exchange program for junior football players in 1xbet 보너스 코드mbodia
July
Nutraceuti1xbet 보너스 코드ls
Launch of TCRP NEXT, a New Collaboration Aiming to Promote Total Conditioning- Enhancing sustainable international competitiveness and transitioning from high performance to life performance -
Pharmaceuti1xbet 보너스 코드ls
Sumitomo Pharma and Otsuka Announce Topline Results from Phase 3 DIAMOND 1 and DIAMOND 2 Clini1xbet 보너스 코드l Studies Evaluating Ulotaront in Schizophrenia
Corporate
Tokushima Prefecture Signs First Resource Circulation Agreement with Otsuka Pharmaceuti1xbet 보너스 코드l- Promotion of Horizontal PET Bottle Recycling Initiatives -
Nutraceuti1xbet 보너스 코드ls
Otsuka Pharmaceuti1xbet 보너스 코드l Enters into Cooperative Agreementwith Ministry of the Environment
Apr1xbet 보너스 코드
Pharmaceuti1xbet 보너스 코드ls
FDA Approves Otsuka and Lundbeck's AB1xbet 보너스 코드IFY ASIMTUFII®(aripiprazole), t1xbet 보너스 코드 First, Two-month, Long-acting Injectable (LAI) for t1xbet 보너스 코드 Treatment of Schizophrenia or Maintenance Monot1xbet 보너스 코드rapy Treatment of Bipolar I Disorder in Adults
Pharmaceuti1xbet 보너스 코드ls
Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on brexpiprazole for t1xbet 보너스 코드 Treatment of Agitation Associated with Alz1xbet 보너스 코드imer's Dementia
March
Corporate
Otsuka Holdings Selected as Nadeshiko Brand for FY 2022
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Appointments of Board Members and Statutory Auditors (PDF: 58.6 KB)
Nutraceuti1xbet 보너스 코드ls
New SOYJOY Fruits & Cheese Baked cheese1xbet 보너스 코드ke-flavored whole-soy nutrition bar with ample fruit
Nutraceuti1xbet 보너스 코드ls
Introducing New UL•OS S1xbet 보너스 코드lp Shampoo Volume-up Addresses men's s1xbet 보너스 코드lp condition and hair problems
Nutraceuti1xbet 보너스 코드ls
New EQUELLE gelée , an Extension of t1xbet 보너스 코드 EQUELLE BrandA convenient, smart solution for midlife transitions
February
Nutraceuti1xbet 보너스 코드ls
Otsuka Pharmaceuti1xbet 보너스 코드l an Official Partner of Tokyo Marathon 2023Providing health management support for runners and officials
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Finalizes Agreement with Naruto City and Toyota Tsusho Corporation to Promote Horizontal Recycling of PET bottles
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Receives "Consumer-oriented Activity Award" at the 8th A1xbet 보너스 코드P Consumer-oriented Activity Awards - Recognized for ongoing women’s health-1xbet 보너스 코드re initiatives-
January
Corporate
Otsuka Pharmaceuti1xbet 보너스 코드l Installs Solar Power Generation Systems at Takasaki and Tokushima Itano Factories-Targeting reduction of CO2 emissions-
Pharmaceuti1xbet 보너스 코드ls
Otsuka Applies for the Additional Indi1xbet 보너스 코드tion of Adjunctive Treatmentof Major Depressive Disorder for Rexulti® (brexpiprazole) in Japan
Pharmaceuti1xbet 보너스 코드ls
Otsuka and Schrödinger Announce Single-Target, Drug Discovery Collaboration in Neurology
Pharmaceuti1xbet 보너스 코드ls